Optimization of tigecycline dosage regimen for different infections in the patients with hepatic or renal impairment.
CONCLUSIONS: It is necessary to optimize tigecycline dosage regimens in patients with hepatic or renal impairment in order to maximise clinical response and minimise the probability of exposure-related toxicity.
PMID: 32757849 [PubMed - as supplied by publisher]
Source: Journal of Chemotherapy - Category: Cancer & Oncology Tags: J Chemother Source Type: research
More News: Acinetobacter | Cancer & Oncology | Chemotherapy | Children | Gastroenteritis | Microbiology | Renal Failure | Study | Toxicology